Orasure Tech Inc (OSUR) 8.56 $OSUR Upgrade Alert for

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Orasure Tech Inc (OSUR) 8.56 $OSUR

Upgrade Alert for OraSure Technologies (OSUR)
Comtex SmarTrend(R) - Tue Aug 30, 3:16AM CDT
OraSure Technologies (NASDAQ:OSUR) was upgraded from Equal Weight to Overweight at Stephens today. The stock closed yesterday at $8.66 on volume of 4.2 million shares, above average daily volume of 465,000. In the past 52 weeks, shares of OraSure Technologies have traded between a low of $3.75 and a high of $14.01 and closed yesterday at $8.66, which is 131% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.6% while the 200-day MA has risen 0.5%.
OSUR: 8.56 (-0.01)

SmarTrend Watching for Potential Pullback in Shares of OraSure Technologies After 8.09% Gain
Comtex SmarTrend(R) - Mon Aug 29, 3:35PM CDT
OraSure Technologies (NASDAQ:OSUR) traded in a range yesterday that spanned from a low of $8.14 to a high of $8.57. Yesterday, the shares gained 8.1%, which took the trading range above the 3-day high of $8.20 on volume of 2.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
OSUR: 8.56 (-0.01)

DNA Genotek's OMNIgene(R)Â? GUT Kit is Proposed as Standardized Test for Worldwide Studies of the Human Microbiome
GlobeNewswire - Mon Aug 29, 5:00AM CDT
OraSure Technologies, Inc. (NASDAQ:OSUR) announced today that a study conducted by Human Longevity, Inc. (HLI) and published in the Journal Scientific Reports (Nature Publishing Group) on August 25, 2016 proposes the use of the OMNIgene?GUT microbiome sample collection and stabilization device sold by OraSure's wholly-owned subsidiary, DNA Genotek Inc., in global microbiome studies. The published report can be found online at http://www.nature.com/articles/srep31731.
OSUR: 8.56 (-0.01)

Look for Shares of OraSure Technologies to Potentially Pullback after Yesterday's 13.93% Rise
Comtex SmarTrend(R) - Wed Aug 24, 1:37PM CDT
OraSure Technologies (NASDAQ:OSUR) traded in a range yesterday that spanned from a low of $7.42 to a high of $8.20. Yesterday, the shares gained 13.9%, which took the trading range above the 3-day high of $7.10 on volume of 5.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
OSUR: 8.56 (-0.01)

OraSure Awarded Up to $16.6 Million to Advance Rapid Zika Tests
GlobeNewswire - Tue Aug 23, 3:00PM CDT
OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, announced today that it has been awarded a contract for up to $16.6 million in total funding from the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response's Biomedical Advanced Research and Development Authority (BARDA) to advance the Company's rapid Zika tests.
OSUR: 8.56 (-0.01)

OraSure Announces 2016 Second Quarter Financial Results
GlobeNewswire - Wed Aug 03, 3:00PM CDT
OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its consolidated financial results for the three and six months ended June 30, 2016.
OSUR: 8.56 (-0.01)

OraSure Technologies to Present at the Canaccord Genuity 36th Annual Growth Conference
GlobeNewswire - Mon Aug 01, 5:00AM CDT
OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the Canaccord Genuity 36 Annual Growth Conference in Boston, Massachusetts. The conference will be simultaneously webcast over the Internet.
OSUR: 8.56 (-0.01)

Medical Instruments & Supplies Equities Roundup -- Endologix, Becton Dickinson, Waters, and OraSure Technologies
PR Newswire - Thu Jun 09, 7:25AM CDT
On Wednesday, June 08, 2016, the NASDAQ Composite ended the trading session at 4,974.64, up 0.26%; the Dow Jones Industrial Average advanced 0.37% to finish at 18,005.05; and the S&P 500 closed at 2,119.12, up 0.33%. The gains were broad based as all the sectors ended the session in positive. ActiveWallSt.com has initiated coverage on the following equities: Endologix Inc. (NASDAQ: ELGX), Becton, Dickinson and Company (NYSE: BDX), Waters Corporation (NYSE: WAT), and OraSure Technologies Inc. (NASDAQ: OSUR). Learn more about these stocks by accessing their free trade alerts at:
BDX: 177.02 (-0.19), ELGX: 12.22 (+0.06), WAT: 156.10 (-1.21), OSUR: 8.56 (-0.01)

Uptrend Call Working As OraSure Technologies Stock Rises 21.3% (OSUR)
Comtex SmarTrend(R) - Tue Jun 07, 1:29AM CDT
SmarTrend identified an Uptrend for OraSure Technologies (NASDAQ:OSUR) on February 10th, 2016 at $6.52. In approximately 4 months, OraSure Technologies has returned 21.26% as of today's recent price of $7.90.
OSUR: 8.56 (-0.01)

OraSure Technologies to Present at the Jefferies 2016 Healthcare Conference
GlobeNewswire - Tue May 31, 5:00AM CDT
OraSure Technologies, Inc. (NASDAQ:OSUR) today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the Jefferies 2016 Healthcare Conference in New York. The conference will be simultaneously webcast over the Internet.
OSUR: 8.56 (-0.01)

Looking for a Growth Stock? Why It is Time to Focus on OraSure Technologies (OSUR)
Zacks Equity Research - Zacks Investment Research - Tue May 24, 8:48AM CDT
OraSure Technologies (OSUR) is seeing solid earnings estimate revision activity, and is a great company from a Zacks Growth perspective.
OSUR: 8.56 (-0.01)

Boston Scientific (BSX): Q1 Earnings Beat amid CRM Woes
Zacks Equity Research - Zacks Investment Research - Thu May 12, 7:18AM CDT
On May 11, 2016, we issued an updated research report on leading medical devices company, Boston Scientific Corporation (BSX). The stock currently carries a Zacks Rank #2 (Buy).
BSX: 24.33 (+0.51), LMAT: 17.76 (-0.62), NUVA: 66.06 (+0.59), OSUR: 8.56 (-0.01)

OraSure Technologies to Hold Virtual Annual Meeting of Stockholders
GlobeNewswire - Tue May 10, 5:44AM CDT
OraSure Technologies, Inc. (NASDAQ:OSUR), announced that its 2016 Annual Meeting of Stockholders will be a completely virtual meeting, conducted as a live webcast beginning at 10:00 a.m. Eastern Time (7:00 a.m. Pacific Time) on Tuesday, May 17, 2016.
OSUR: 8.56 (-0.01)

OraSure Announces 2016 First Quarter Financial Results
GlobeNewswire - Wed May 04, 3:00PM CDT
OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its consolidated financial results for the first quarter ended March 31, 2016.
OSUR: 8.56 (-0.01)

OraSure Technologies to Present at the UBS 2016 Global Healthcare Conference
GlobeNewswire - Tue May 03, 5:00AM CDT
OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the UBS 2016 Global Healthcare Conference in New York. The conference will be simultaneously webcast over the Internet.
OSUR: 8.56 (-0.01)

OraSure Technologies Appoints New Chief Science Officer
GlobeNewswire - Fri Apr 15, 5:00AM CDT
OraSure Technologies, Inc. (NASDAQ:OSUR) announced today that Michael Reed, Ph.D. has been named as the Company's Senior Vice President of Research and Development and Chief Science Officer. He will begin working at the Company on April 18, 2016.
OSUR: 8.56 (-0.01)

OraSure Technologies Earnings Conference Call Invitation
GlobeNewswire - Wed Apr 13, 5:00AM CDT
OraSure Technologies, Inc. (NASDAQ:OSUR) has scheduled its regular earnings conference call covering 2016 first quarter financial results, 2016 second quarter financial guidance and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, May 4, 2016.
OSUR: 8.56 (-0.01)

CVS Health Strong on Omnicare Buyout, Integration Prospects
Zacks Equity Research - Zacks Investment Research - Tue Apr 12, 1:40PM CDT
On Apr 12, 2016, we issued an updated research report on Rhode Island-based pharmacy retail giant CVS Health Corp. (CVS).
BAX: 46.18 (-0.55), RMD: 67.12 (+0.43), CVS: 93.37 (-0.03), OSUR: 8.56 (-0.01)

C.R. Bard at 52-Week High, Product Suite Holds the Key
Zacks Equity Research - Zacks Investment Research - Mon Apr 04, 11:40AM CDT
Shares of C.R. Bard Inc (BCR) rallied to a new 52-week high of $205.52 on Apr 1, eventually closing a tad bit lower at $204.69.
BCR: 221.50 (+0.66), ALGN: 93.76 (+0.86), BAX: 46.18 (-0.55), OSUR: 8.56 (-0.01)

Thermo Fisher Steals Affymetrix Deal, Expands Antibody Line
Zacks Equity Research - Zacks Investment Research - Mon Apr 04, 10:10AM CDT
With the closure of the Affymetrix deal, Thermo Fisher(TMO) expects to enjoy an extended antibody portfolio, which will boost the company's leadership in biosciences.
TMO: 150.95 (-1.24), BAX: 46.18 (-0.55), OFIX: 45.52 (+0.41), OSUR: 8.56 (-0.01)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pony.ai & Toyota Launch 1,000 Gen-7 Robotaxis in China

Updated Category News Views 29

Revving Up the Autonomous Ride Revolution Not every day you see two giants, Pony.ai and Toyota, join forces to shake up the way folks get from A to B. But here we are — they’ve fired up their engines in Guangzhou, unleashing their Gen-7 bZ4X Robotaxis for commercial use. And let me tell you, this is no shot in the dark. With plans to dot about 1,000 of these...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 310

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 421

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 308

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
LONGi's Four Paths to Global Green Development

Updated Category News Views 62

LONGi's Vision: A Cleaner, Greener Future Amidst the buzz at COP31 in Antalya, LONGi is making waves with promises of a cleaner future. They're not just throwing around eco-friendly slogans—this company's laying down real pathways to tackle climate change, one solar panel at a time. Aiming for Industrial Transformation LONGi's got their sights set on shaking up...

Continue Reading
Midea's R290 Tech: Real Green Cooling Revolution?

Updated Category News Views 66

A Fresh Breeze in Sustainable Cooling In the middle of Kigali’s innovation oasis, Midea RAC stood out at MOP38, the 38th Meeting of the Parties to the Montreal Protocol, flexing its sustainable tech muscles. We're talking about their R290 air conditioning technology—a natural refrigerant with zero ozone footprint and a global warming potential of a mere three. This is...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 187

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 34

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 309

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 431

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading

Top 5 Most Recently Viewed Articles

Investing in Kronos Worldwide: Why Now is the Time

Updated Category News Views 150

Why Kronos Worldwide is a Smart Investment Choice Kronos Worldwide, Inc. (NYSE: KRO) is poised to benefit from a rising demand for titanium dioxide (TiO2) and is experiencing less pricing pressure this year. The company's cost-saving strategies are expected to enhance profit margins, making this an excellent time to think about investing in KRO. With a promising outlook,...

Continue Reading
Old National Transforms Wealth Advisory Services for Clients

Updated Category News Views 333

Old National Unveils New Name for Wealth Advisory Division Old National Bancorp has made a notable change in its wealth advisory division by renaming Old National Investments to Old National Wealth Advisors (ONWA). This rebranding reflects the extensive range of services that the division's financial professionals offer to their clients. With a dedicated team of...

Continue Reading
Archer's Exciting Rebrand Elevates Their Meat Snack Lineup

Updated Category News Views 693

Archer Embraces a Fresh Brand Identity Fast-rising meat snack sensation, Archer, has undergone a significant transformation with a bold new brand identity that is sure to turn heads. Formerly known as Country Archer Provisions, Archer has introduced a streamlined name, a vibrant logo, and new packaging designed to enhance brand recognition and consumer engagement in a...

Continue Reading
Noveon Magnetics Secures $215 Million Investment for Growth

Updated Category News Views 290

Noveon Magnetics Secures Significant Investment to Enhance Manufacturing Noveon Magnetics, Inc., recognized as a prominent U.S. manufacturer of sintered rare earth permanent magnets, has successfully closed a remarkable $215 million Series C financing round. This initiative was led primarily by One Investment Management, who contributed $200 million. The funds will...

Continue Reading
Luckin Coffee Celebrates 30,000 Stores with New Flagship Concept

Updated Category News Views 253

Luckin Coffee Marks a Milestone with Its 30,000th Store In an impressive display of growth and innovation, Luckin Coffee, a leading retail coffee chain, has officially launched its 30,000th store, the Origin Flagship. This milestone highlights the brand's dedication to quality and sustainable practices, aimed at meeting the ever-evolving demands of coffee enthusiasts....

Continue Reading